Promiscuity of anticancer drugs: How selective should targeted agents be? Suggestions from early clinical trial observations.

Research output: Chapter/Conference proceedingChapterAcademic

Original languageUndefined/Unknown
Title of host publicationASCO Educational Book
EditorsMC Perry
Place of PublicationAlexandria
PublisherAmerican Society of Clinical Oncology
Pages175-179
Number of pages5
Publication statusPublished - 2004

Cite this